← Back to all trials
Recruiting
NCT07388745
ESPB vs SPSIP for Postoperative Analgesia After CABG
Conditions: Coronary Arterial Disease, Coronary Artery Bypass Grafting (CABG) Surgery, Postoperative Pain Management
Sex: All
Ages: 45 Years – 85 Years
Healthy volunteers: No
Phase: NA
Enrollment: 64
Sponsor: Kutahya Health Sciences University
Location: Kütahya Health Sciences University Hospital Kütahya
Summary
This prospective, randomized, active-controlled, double-blind, parallel-group study compares the postoperative analgesic efficacy and safety of ultrasound-guided bilateral Erector Spinae Plane Block (ESPB) versus bilateral Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in adult patients (45-85 years, ASA I-III) undergoing elective coronary artery bypass graft surgery. The primary outcome is postoperative pain intensity assessed by Numeric Rating Scale (NRS) at 2, 4, 8, 16, 24, and 48 hours after surgery. Secondary outcomes include intraoperative fentanyl/remifentanil consumption, postoperative morphine consumption, patient-controlled analgesia (PCA) demand/delivery parameters (if PCA is used), need for rescue analgesics, extubation and mobilization times, peak inspiratory flow measured by incentive spirometry at predefined time points, ICU and hospital length of stay, recovery quality (QoR-15 at 0, 24, and 48 hours), mortality, and block-related adverse events.
Eligibility Criteria
Inclusion Criteria:
* Age 45-85 years
* Scheduled for elective coronary artery bypass graft (CABG) surgery
* American Society of Anesthesiologists (ASA) I-II-III
* Patients who provide written informed consent and agree to participate in the study
Exclusion Criteria:
* Emergency cases
* ASA IV-V
* Known allergy to local anesthetics
* Coagulopathy (platelet count \1.5, aPTT \>1.5× normal)
* Infection at the block injection site
* Pregnancy
* Patients who do not provide written informed consent or decline to participate after being informed
Source: ClinicalTrials.gov (NCT07388745). StuddyBuddy aggregates publicly available trial information.